Basic Search  |  Summaries  |  Advanced Search

Violation Tracker Individual Record

Company: Ranbaxy
Current Parent Company: Sun Pharmaceuticals
Parent at the Time of the Penalty Announcement:  subscribe to see this data field
Penalty: $9,862,500
Year: 2024
Date: December 12, 2024
Offense Group: competition-related offenses
Primary Offense: price-fixing or anti-competitive practices
Violation Description: Ranbaxy agreed to pay almost $10 million to resolve allegations of conspiring to delay the introduction of a generic version of Lipitor, violating antitrust law.
Level of Government: state
Action Type: agency action
Agency: West Virginia Attorney General
Civil or Criminal Case: civil
Facility State: West Virginia
HQ Country of Current Parent: India
Ownership Structure of Current Parent: publicly traded
Major Industry of Current Parent: pharmaceuticals
Specific Industry of Current Parent: pharmaceuticals
Source of Data: (click here)
Source Notes: If an online information source is not working, check the Violation Tracker Data Sources page for an updated link.
Current parent company note: Parent-subsidiary relationship is current as of the most recent revision listed in the Update Log.